BR9908885A - Medicamento para a profilaxia e/ou tratamento de mastocarcinoma, compreendendo um inibidor esteróide de aromatase - Google Patents

Medicamento para a profilaxia e/ou tratamento de mastocarcinoma, compreendendo um inibidor esteróide de aromatase

Info

Publication number
BR9908885A
BR9908885A BR9908885-1A BR9908885A BR9908885A BR 9908885 A BR9908885 A BR 9908885A BR 9908885 A BR9908885 A BR 9908885A BR 9908885 A BR9908885 A BR 9908885A
Authority
BR
Brazil
Prior art keywords
treatment
aromatase inhibitor
mastocarcinoma
prophylaxis
steroid aromatase
Prior art date
Application number
BR9908885-1A
Other languages
English (en)
Inventor
Alfred Schmidt
Heinrich Wieland
Original Assignee
S W Patentverwertungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9908885(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S W Patentverwertungs Gmbh filed Critical S W Patentverwertungs Gmbh
Publication of BR9908885A publication Critical patent/BR9908885A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"MEDICAMENTO PARA A PROFILAXIA E/OU TRATAMENTO DE MASTOCARCINOMA, COMPREENDENDO UM INIBIDOR ESTERóIDE DE AROMATASE"<D>. A invenção refere-se ao uso de um inibidor esteróide de aromatase para produzir um medicamento formulado para uso tópico, para a prevenção e/ou tratamento de carcinoma mamário. O medicamento de invenção oferece uma maneira de evitar os efeitos secundários associdados com uso sistemático. é portanto possível realizar um tratamento preventivo primário ou ainda um tratamento preventivo secundário depois do aparecimento de um carcinoma mamário.
BR9908885-1A 1998-03-18 1999-03-03 Medicamento para a profilaxia e/ou tratamento de mastocarcinoma, compreendendo um inibidor esteróide de aromatase BR9908885A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98104949A EP0943333A1 (de) 1998-03-18 1998-03-18 Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
PCT/EP1999/001374 WO1999047143A1 (de) 1998-03-18 1999-03-03 Medikament zur prophylaxe und/oder behandlung des mammakarzinoms enthaltend einen steroidalen aromataseinhibitor

Publications (1)

Publication Number Publication Date
BR9908885A true BR9908885A (pt) 2000-11-21

Family

ID=8231611

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908885-1A BR9908885A (pt) 1998-03-18 1999-03-03 Medicamento para a profilaxia e/ou tratamento de mastocarcinoma, compreendendo um inibidor esteróide de aromatase

Country Status (19)

Country Link
EP (2) EP0943333A1 (pt)
JP (1) JP4920822B2 (pt)
KR (1) KR100778803B1 (pt)
CN (1) CN1168448C (pt)
AT (1) ATE230995T1 (pt)
AU (1) AU751040B2 (pt)
BR (1) BR9908885A (pt)
CA (1) CA2324077C (pt)
CZ (1) CZ292643B6 (pt)
DE (1) DE59904042D1 (pt)
DK (1) DK1063998T3 (pt)
ES (1) ES2190201T3 (pt)
HU (1) HU226105B1 (pt)
ID (1) ID26965A (pt)
IL (1) IL138292A (pt)
PL (1) PL343100A1 (pt)
RU (1) RU2225206C2 (pt)
SK (1) SK285349B6 (pt)
WO (1) WO1999047143A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042411A1 (de) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Exemestan
DE10054294A1 (de) * 2000-11-02 2002-05-16 Heinrich Wieland Topische Behandlung bei der Mastalgie
JP4524296B2 (ja) * 2007-03-30 2010-08-11 生化学工業株式会社 発毛促進剤
DE102007032468A1 (de) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
RS57635B1 (sr) * 2011-01-31 2018-11-30 Lucolas M D Ltd Kozmetička primena
ES2694582T3 (es) * 2011-01-31 2018-12-21 Lucolas-M.D. Ltd. Combinaciones de inhibidores de aromatasa y antioxidantes
US11850451B2 (en) 2011-01-31 2023-12-26 Lucolas-M.D. Ltd. Cosmetic compositions and methods for improving skin conditions
EP3666276A1 (en) * 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
JPS6345294A (ja) * 1986-04-07 1988-02-26 Shionogi & Co Ltd アロマタ−ゼ阻害ステロイド誘導体
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
FR2656310B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
PT689536E (pt) * 1993-03-16 2001-11-30 Pfizer Derivados de naftaleno
JPH07215992A (ja) * 1993-12-07 1995-08-15 Teikoku Hormone Mfg Co Ltd ６−又は７−置換アンドロスタ−１，４−ジエン誘導体
WO1996008231A1 (en) * 1994-09-14 1996-03-21 Central Sheffield University Hospitals Nhs Trust Control of hair growth
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
EP0907351B2 (de) * 1996-03-29 2012-04-18 Keyvest GmbH Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
EP0930876B2 (en) * 1996-07-22 2010-07-07 Renovo Limited Use of compounds that promote oestrogenic activity for acclerating the healing of skin wounds

Also Published As

Publication number Publication date
CA2324077C (en) 2008-07-29
AU751040B2 (en) 2002-08-08
CN1168448C (zh) 2004-09-29
CZ20003256A3 (cs) 2001-04-11
SK13422000A3 (sk) 2001-05-10
RU2225206C2 (ru) 2004-03-10
KR20010034603A (ko) 2001-04-25
HUP0101005A2 (hu) 2001-08-28
IL138292A0 (en) 2001-10-31
SK285349B6 (sk) 2006-11-03
ATE230995T1 (de) 2003-02-15
DK1063998T3 (da) 2003-05-12
JP2002506823A (ja) 2002-03-05
WO1999047143A1 (de) 1999-09-23
HU226105B1 (en) 2008-04-28
DE59904042D1 (de) 2003-02-20
EP1063998B1 (de) 2003-01-15
EP0943333A1 (de) 1999-09-22
CZ292643B6 (cs) 2003-11-12
AU3143499A (en) 1999-10-11
JP4920822B2 (ja) 2012-04-18
KR100778803B1 (ko) 2007-11-27
IL138292A (en) 2005-08-31
PL343100A1 (en) 2001-07-30
CA2324077A1 (en) 1999-09-23
ES2190201T3 (es) 2003-07-16
EP1063998A1 (de) 2001-01-03
CN1301165A (zh) 2001-06-27
ID26965A (id) 2001-02-22

Similar Documents

Publication Publication Date Title
BR9806060A (pt) Composto, composição farmacêutica e processos para tratar um paciente sofrendo de um estado doentio, para inibir o fator xa, e, para inibir a formação de trombina.
BR9911072A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior
BR9908030A (pt) Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR0116607A (pt) Derivados de glicopiranosiloxipirazol e uso dos mesmos em medicamentos
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
BR0113447A (pt) Método de tratamento ou prevenção do câncer em um ser humano, e, composição farmacêutica
BRPI0308663B8 (pt) uso de inibidores de il-18 para o tratamento e/ou prevenção de doenças vasculares periféricas
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
BR0115162A (pt) Tratamentos antitumorais eficazes
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
AU4024797A (en) Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
KR970061244A (ko) 치매 치료용 약학 조성물
BR9908885A (pt) Medicamento para a profilaxia e/ou tratamento de mastocarcinoma, compreendendo um inibidor esteróide de aromatase
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
ID24870A (id) Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
PT1206444E (pt) Compostos que inibem a actividade da triptase
HUP9900978A2 (hu) Dioszgenint tartalmazó készítmény
ATE421357T1 (de) Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/565, A61P 35/00

Ipc: A61K 31/565 (2009.01), A61P 35/00 (2009.01)

B25A Requested transfer of rights approved

Owner name: S.W. VERMOEGENSVERWALTUNGS GMBH (GB)

Free format text: TRANSFERIDO DE: S.W. PATENTVERWERTUNGS GESELLSCHAFT MBH

B25A Requested transfer of rights approved

Owner name: S.W. PATENTVERWERTUNGS LIMITED (GB)

Free format text: TRANSFERIDO DE: S.W. VERMOEGENSVERWALTUNGS GMBH

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.